Pharma Marketletter - Positive new data for Merck & Co’s Singulair.
Monday, September 29th, 2008Results presented at the 13th European Respiratory Society Annual Congress in Vienna, Austria, demonstrated that young children whose asthma is triggered by upper respiratory infections experience fewer asthma attacks when treated with Merck & Co’s Singulair (montelukast sodiu…
